Molecular Mechanisms in the Pathogenesis of Idiopathic Nephrotic Syndrome
Editat de Kazunari Kanekoen Limba Engleză Paperback – 23 aug 2016
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1001.66 lei 43-57 zile | |
Springer – 23 aug 2016 | 1001.66 lei 43-57 zile | |
Hardback (1) | 664.30 lei 38-44 zile | |
Springer – 25 noi 2015 | 664.30 lei 38-44 zile |
Preț: 1001.66 lei
Preț vechi: 1054.38 lei
-5% Nou
Puncte Express: 1502
Preț estimativ în valută:
191.70€ • 199.12$ • 159.23£
191.70€ • 199.12$ • 159.23£
Carte tipărită la comandă
Livrare economică 03-17 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9784431562795
ISBN-10: 4431562796
Pagini: 240
Ilustrații: VIII, 240 p. 21 illus., 16 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.35 kg
Ediția:Softcover reprint of the original 1st ed. 2016
Editura: Springer
Colecția Springer
Locul publicării:Tokyo, Japan
ISBN-10: 4431562796
Pagini: 240
Ilustrații: VIII, 240 p. 21 illus., 16 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.35 kg
Ediția:Softcover reprint of the original 1st ed. 2016
Editura: Springer
Colecția Springer
Locul publicării:Tokyo, Japan
Cuprins
Part 1. Introduction.- 1. History of Research on Pathogenesis of Idiopathic Nephrotic Syndrome.- Part 2. Minimal-change nephrotic syndrome (MCNS).- 2. Hemopexin in Minimal Change Nephrotic Syndrome.- 3. Angiopoietin-like-4 (Angptl4) in MCNS.- 4. Co-stimulatory molecule CD80 (B7.1) in MCNS.- 5. Energy and Mammalian target of rapamycin complex 1 (mTORC1) in minimal change nephrotic syndrome.- 6. The role of c-mip in the pathogenesis of Minimal Change Nephrotic Syndrome.- 7. REGULATORY T-CELLS AND OXIDATIVE STRESS IN MINIMAL CHANGE NEPHROPATHY.- 8. CYTOKINES AS ACTIVE FACTORS IN MINIMAL CHANGE NEPHROTIC SYNDROME.- Part 3. Focal segmental glomerulosclerosis (FSGS).- 9. Soluble urokinase-type plasminogen activator receptor (suPAR) in Focal Segmental Glomerulosclerosis.- 10. CYTOKINES AS ACTIVE FACTORS IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS.- Part 4. Idiopathic Membranous Nephropathy (IMN).- 11. M-Type Phospholipase A2 Receptor (PLA2R) and Thrombospondin Type-1 Domain-Containing 7A (THSD7A) in Membranous Nephropathy.- 12. Cationic Bovine Serum Albumin as Cause of Membranous Nephropathy: From Mice to Men.- Part 5. Treatment in Idiopathic Nephrotic Syndrome.- 13. Podocytes as a direct target of drugs used in Idiopathic Nephrotic Syndrome.
Textul de pe ultima copertă
This comprehensive book reviews our current state of knowledge about the pathogenesis of idiopathic nephrotic syndrome (INS), which comprises a heterogeneous group of diseases with distinct histological characteristics, such as minimal-change nephrotic syndrome (MCNS), focal segmental glomerulosclerosis (FSGS), and idiopathic membranous nephropathy (IMN). As the word “idiopathic” indicates, the pathogenesis of INS remains unclear. Historically, T-cell dysfunction has been thought to play an important part in the pathogenesis of MCNS, while circulating vascular permeabilities have been believed to induce proteinuria in FSGS. The book further describes recent advances in molecular biology, which have allowed us to speculate on the interactions between visceral glomerular epithelial cells (podocytes) and the relative significance of several molecules in the pathogenesis of INS, such as reactive oxygen species, nuclear factor-kappa B, CD80, angiopoietin-like 4, cardiotrophin-like cytokine-1, and M-type phospholipase A2 receptor. The normally rapid pace of scientific progress occasionally devolves into a state of chaos, and the pathogenetic research on INS is one such case. This volume will help researchers and scientists to collaborate, share resources, and expedite the design of protocols to evaluate the putative factors.
Caracteristici
Brings together all of the latest research by top researchers on molecular mechanisms in the pathogenesis of INS Represents one putative pathogenetic molecule in each chapter and reviews its role, mechanism, and prospects as a biomaker or for new drugs Provides valuable reading for physicians, pediatricians, nephrologists, and individuals researching nephrotic syndrome